61 related articles for article (PubMed ID: 28430290)
21. The incidence of post-mortem neurodegenerative and cerebrovascular pathology in mixed dementia.
De Reuck J; Deramecourt V; Cordonnier C; Pasquier F; Leys D; Maurage CA; Bordet R
J Neurol Sci; 2016 Jul; 366():164-166. PubMed ID: 27288798
[TBL] [Abstract][Full Text] [Related]
22. Aging and cerebrovascular lesions in pure and in mixed neurodegenerative and vascular dementia brains: a neuropathological study.
De Reuck J; Maurage CA; Deramecourt V; Pasquier F; Cordonnier C; Leys D; Bordet R
Folia Neuropathol; 2018; 56(2):81-87. PubMed ID: 30509027
[TBL] [Abstract][Full Text] [Related]
23. Topographic distribution of white matter changes and lacunar infarcts in neurodegenerative and vascular dementia syndromes: A post-mortem 7.0-tesla magnetic resonance imaging study.
De Reuck J; Auger F; Durieux N; Cordonnier C; Deramecourt V; Pasquier F; Maurage CA; Leys D; Bordet R
Eur Stroke J; 2016 Jun; 1(2):122-129. PubMed ID: 31008274
[TBL] [Abstract][Full Text] [Related]
24. Post-mortem 7.0-tesla magnetic resonance study of cortical microinfarcts in neurodegenerative diseases and vascular dementia with neuropathological correlates.
De Reuck J; Deramecourt V; Auger F; Durieux N; Cordonnier C; Devos D; Defebvre L; Moreau C; Caparros-Lefebvre D; Bordet R; Maurage CA; Pasquier F; Leys D
J Neurol Sci; 2014 Nov; 346(1-2):85-9. PubMed ID: 25129206
[TBL] [Abstract][Full Text] [Related]
25. The Topography of Cortical Microinfarcts in Neurodegenerative Diseases and in Vascular Dementia: A Postmortem 7.0-Tesla Magnetic Resonance Imaging Study.
De Reuck JL; Auger F; Durieux N; Cordonnier C; Deramecourt V; Pasquier F; Maurage CA; Leys D; Bordet R
Eur Neurol; 2016; 76(1-2):57-61. PubMed ID: 27379570
[TBL] [Abstract][Full Text] [Related]
26. Frequency and topography of small cerebrovascular lesions in vascular and in mixed dementia: a post-mortem 7-tesla magnetic resonance imaging study with neuropathological correlates.
De Reuck J; Auger F; Durieux N; Deramecourt V; Maurage CA; Cordonnier C; Pasquier F; Leys D; Bordet R
Folia Neuropathol; 2017; 55(1):31-37. PubMed ID: 28430290
[No Abstract] [Full Text] [Related]
27. Neuropathological evaluation of mixed dementia.
Jellinger KA; Attems J
J Neurol Sci; 2007 Jun; 257(1-2):80-7. PubMed ID: 17324442
[TBL] [Abstract][Full Text] [Related]
28. Defining the neuropathological background of vascular and mixed dementia and comparison with magnetic resonance imaging findings.
Gold G
Front Neurol Neurosci; 2009; 24():86-94. PubMed ID: 19182466
[TBL] [Abstract][Full Text] [Related]
29. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease.
Kalaria RN
Acta Neuropathol; 2016 May; 131(5):659-85. PubMed ID: 27062261
[TBL] [Abstract][Full Text] [Related]
30. Post-mortem assessment in vascular dementia: advances and aspirations.
McAleese KE; Alafuzoff I; Charidimou A; De Reuck J; Grinberg LT; Hainsworth AH; Hortobagyi T; Ince P; Jellinger K; Gao J; Kalaria RN; Kovacs GG; Kövari E; Love S; Popovic M; Skrobot O; Taipa R; Thal DR; Werring D; Wharton SB; Attems J
BMC Med; 2016 Aug; 14(1):129. PubMed ID: 27600683
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and management of vascular cognitive impairment and dementia.
Erkinjuntti T
J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
[TBL] [Abstract][Full Text] [Related]
32. Pathology and pathophysiology of vascular cognitive impairment. A critical update.
Jellinger KA
Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer disease and cerebrovascular pathology: an update.
Jellinger KA
J Neural Transm (Vienna); 2002 May; 109(5-6):813-36. PubMed ID: 12111471
[TBL] [Abstract][Full Text] [Related]
34. Towards defining the neuropathological substrates of vascular dementia.
Kalaria RN; Kenny RA; Ballard CG; Perry R; Ince P; Polvikoski T
J Neurol Sci; 2004 Nov; 226(1-2):75-80. PubMed ID: 15537525
[TBL] [Abstract][Full Text] [Related]
35. Imaging of static brain lesions in vascular dementia: implications for clinical trials.
Erkinjuntti T; Bowler JV; DeCarli CS; Fazekas F; Inzitari D; O'Brien JT; Pantoni L; Rockwood K; Scheltens P; Wahlund LO; Desmond DW
Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S81-90. PubMed ID: 10609686
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
